ALK-Abelló (ALK) AGM 2023 summary
Event summary combining transcript, slides, and related documents.
AGM 2023 summary
26 Oct, 2026Financial performance review
Annual report 2022 adopted; the Board of Directors and Board of Management were discharged.
Board and executive committee updates
Anders Hedegaard and Lene Skole re-elected as Chair and Vice Chair, respectively.
Gitte Aabo, Lars Holmqvist, Bertil Lindmark and Alan Main re-elected; Jesper Høiland newly elected to the Board.
Dividend announcements
No ordinary dividend declared in accordance with the approved annual report for 2022.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ALK-Abelló
- No ordinary dividend; Alan Main joined the Board as governance measures were approved.ALK
AGM 2022 - Governance proposals passed; directors were re-elected and no ordinary dividend was declared.ALKAGM 2024
- 15% revenue growth and 65% EBIT increase, with strong outlook and major product launches ahead.ALKQ4 2024
- Q2 2026 saw 18% revenue and 19% EBIT growth, with upgraded full-year outlook.ALKQ2 2026
- 18% revenue and 19% EBIT growth in Q2, with upgraded full-year outlook and strong tablet sales.ALKQ2 2026
- 2025 growth, a DKK 355 million dividend and approved governance changes.ALKAGM 2026
- Record growth, reinvestment, Board re-election and no 2024 dividend.ALKAGM 2025
- Q3 revenue up 18% and EBIT margin at 23%, driven by tablet and JextⓇ sales, with neffyⓇ deal fueling growth.ALKQ3 2024
- Q1 saw 12% revenue growth, 50% EBIT surge, and strong pediatric and neffy® product momentum.ALKQ1 2025